KING-JONES HEIDY (See Remarks) sold 91.0% of their position (28.93K shares) of SPYRE THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.63M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+28.93K
Price / share
$14.50
Trade value
$419.53K
% of position
Common Stock
Shares
−400.00
Price / share
$89.24
Trade value
$35.70K
% of position
Common Stock
Shares
−16.61K
Price / share
$90.35
Trade value
$1.50M
% of position
Common Stock
Shares
−7.23K
Price / share
$91.35
Trade value
$660.28K
% of position
Common Stock
Shares
−2.10K
Price / share
$92.70
Trade value
$194.67K
% of position
Common Stock
Shares
−2.60K
Price / share
$93.46
Trade value
$243K
% of position
Net shares
+0.00
Net value
-$2.21M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/1/2026 | M · Option Exercise | +28.93K | $14.50 | $419.53K | 1017.0% | 2.85K | 31.78K |
| Common Stock Direct | 10/1/2026 | S · Sale | −400.00 | $89.24 | $35.70K | 1.3% | 31.78K | 31.38K |
| Common Stock Direct | 10/1/2026 | S · Sale | −16.61K | $90.35 | $1.50M | 52.9% | 31.38K | 14.77K |
| Common Stock Direct | 10/1/2026 | S · Sale | −7.23K | $91.35 | $660.28K | 48.9% | 14.77K | 7.54K |
| Common Stock Direct | 10/1/2026 | S · Sale | −2.10K | $92.70 | $194.67K | 27.8% | 7.54K | 5.45K |
| Common Stock Direct | 10/1/2026 | S · Sale | −2.60K | $93.46 | $243K | 47.8% | 5.45K | 2.85K |
| Total | +0.00 | -$2.21M | ||||||
Stock Option (Right to Buy)
Common Stock
28.93K shares
Shares
−28.93K
Strike price
14.50
Held after
482.48K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock28.93K shares | 10/1/2026 | M · Option Exercise | −28.93K | 14.50 | — | 482.48K |